Become an NF Patient Representative
15 January 2021
As patients and caregivers of those with Neurofibromatosis Type 1, Neurofibromatosis Type 2, or Schwannomatosis, your voices and lived experiences play an important role in determining the direction that research should take!
The REiNS (Response Evaluation in Neurofibromatosis and Schwannomatosis) Collaboration is looking for patients and caregivers to help in the fight to cure all types of NF by helping to design clinical trials. This is a chance for you to make a real difference in finding treatments for these conditions. A scientific background is not necessary – lived experience with neurofibromatosis and schwannomatosis is. We are looking for people from all backgrounds, including people of all genders, races, ethnicities, education level, and health status.
For more information about REiNS, please watch this video at
If you are interested in joining the patient representative program, please click the link below.
Filter News

Tom GK- Hearing Loss: The Musical
Find out more about the musical and how you can secure your ticket here
Read More
Nerve Tumours UK joins the “Embracing Complexity” Coalition
Find out more about the coalition we have decided to join
Read More
Researching NF1
Rory Deasy has conducted research into the treatment of children with NF1. Here he talks about his research journey.
Read More
Megan’s Journey
Megan talks about her experiences of being a student with NF and what she took away from the NF conference in San Fransico
Read More
Aldo goes to Primary School
Find out more about the book aimed at helping people understand the life of an autistic boy going through primary school here
Read More
Eva’s Races
Eva has run 3 races over the past year for NTUK, find out what has been motivating her here:
Read More
Carl’s Story in memory of his sister who had NF2
Carl recently hosted his own wrestling event in memory of his late sister, find out more on his story here:
Read More
NTUK Dolphins at the Swim Serpentine 2019
Find out more about the incredible day for all involved at Hyde Park here:
Read More